StonvexLoading…
StonvexStonvexStonvexCore line items from EXP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $2.26B | $2.26B | $2.15B | $1.86B |
Operating Income | Not available | $716.90M | $674.74M | $552.10M |
Net Income | $463.42M | $477.64M | $461.54M | $374.25M |
EPS (Diluted) | $13.77 | $13.61 | $12.46 | $9.14 |
Total Assets | $3.26B | $2.95B | $2.78B | $2.58B |
Total Liabilities | $1.81B | $1.64B | $1.60B | $1.45B |
Cash & Equivalents | $20.40M | $34.92M | $15.24M | $19.42M |
Free Cash Flow OCF − CapEx | $353.27M | $443.63M | $431.58M | $443.05M |
Shares Outstanding | 34.14M | 32.97M | 35.77M | 38.71M |